Rankings
▼
Calendar
FLGT Q2 2019 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$447M
Q2 2019 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$8M
+56.0% YoY
Gross Profit
$5M
57.0% margin
Operating Income
$295,000
3.5% margin
Net Income
$331,000
3.9% margin
EPS (Diluted)
$0.02
QoQ Revenue Growth
+56.9%
Cash Flow
Operating Cash Flow
$675,000
Free Cash Flow
$176,000
Stock-Based Comp.
$737,000
Balance Sheet
Total Assets
$56M
Total Liabilities
$5M
Stockholders' Equity
$51M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$5M
+56.0%
Gross Profit
$5M
$3M
+68.2%
Operating Income
$295,000
-$1M
+129.5%
Net Income
$331,000
-$1M
+131.6%
Geographic Segments
UNITED STATES
$7M
79%
Other Countries
$1M
15%
CANADA
$516,000
6%
← FY 2019
All Quarters
Q3 2019 →